These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 997846)
1. [Certain mechanisms of radiation-induced pathomorphism of neoplasms in man and their practical use]. Lavnikova GA Vestn Akad Med Nauk SSSR; 1976; (6):13-9. PubMed ID: 997846 [No Abstract] [Full Text] [Related]
2. [Quantitative evaluation of tumor radiation reactions by their radiobiological parameters]. Lisin VA; Musabaeva LI Med Radiol (Mosk); 1983 Dec; 28(12):30-4. PubMed ID: 6645839 [TBL] [Abstract][Full Text] [Related]
3. Radiation biology at clinically relevant fractions. Peters LJ; Brock WA; Travis EL Important Adv Oncol; 1990; ():65-83. PubMed ID: 2182524 [No Abstract] [Full Text] [Related]
4. [Therapeutic pathomorphism of neoplasms in man in practical and theoretical aspects]. Lushnikov EF Vestn Akad Med Nauk SSSR; 1976; (6):7-12. PubMed ID: 997855 [No Abstract] [Full Text] [Related]
6. Normal tissue tolerance and damage. Cancer; 1976 Apr; 37(4 Suppl):2046-55. PubMed ID: 1260701 [No Abstract] [Full Text] [Related]
7. [Problems of radiation therapy of malignant tumors]. Kozlova AV Klin Med (Mosk); 1975 Aug; 53(8):118-22. PubMed ID: 1186076 [No Abstract] [Full Text] [Related]
8. [Cancer and radiotherapy(3). Radiobiology for radiotherapy]. Ando K Iyodenshi To Seitai Kogaku; 1982 Apr; 20(2):122-9. PubMed ID: 6752496 [No Abstract] [Full Text] [Related]
9. [Twice daily fractioning : application in the irradiation of severe skin neoplasms (author's tranls)]. Larra F; Pinet F J Radiol Electrol Med Nucl; 1976 Nov; 57(11):835-7. PubMed ID: 1011190 [TBL] [Abstract][Full Text] [Related]
10. [A method of optimizing dose fractionation in radiotherapy of malignant tumors in terms of the Ellis concept]. Lisin VA Med Radiol (Mosk); 1984 Dec; 29(12):83-7. PubMed ID: 6513758 [No Abstract] [Full Text] [Related]
12. [Inhibition of tumor cell growth by the action of high-energy sources]. Rosell D; Robles JE; Abad JI; Agúera LG; De Castro F; Zudaire JJ; Berián JM Actas Urol Esp; 1993 Sep; 17(8):487-90. PubMed ID: 8237526 [TBL] [Abstract][Full Text] [Related]
13. Survival curve description for fractionated radiation therapy. Kozubek S Neoplasma; 1982; 29(2):135-48. PubMed ID: 7110444 [TBL] [Abstract][Full Text] [Related]
14. Poisson formulas for tumor control probability with clonogen proliferation. Deasy J Radiat Res; 1996 Mar; 145(3):382-4. PubMed ID: 8927706 [No Abstract] [Full Text] [Related]
15. An effective dose computation model for fractionated radiation dose. Akanuma A Radiat Med; 1983; 1(2):155-60. PubMed ID: 6679907 [TBL] [Abstract][Full Text] [Related]
16. Achievements to be expected from new developments in tumour radiotherapy. Tubiana M Eur J Cancer (1965); 1974 Jun; 10(6):373-80. PubMed ID: 4445966 [No Abstract] [Full Text] [Related]
18. [How is it considered to advance radiotherapy from biological and clinical standpoint of view?]. Sakamoto K Gan No Rinsho; 1990 Oct; 36(13):2387-92. PubMed ID: 2250361 [TBL] [Abstract][Full Text] [Related]
19. [Dose response: is it present in clinical radiotherapy?]. Kondo M Rinsho Hoshasen; 1986 Aug; 31(8):921-7. PubMed ID: 3534367 [No Abstract] [Full Text] [Related]
20. [Repopulation and time factor in radiotherapy]. Tubiana M; Malaise E; Frindel E J Radiol Electrol Med Nucl; 1971 Dec; 52(12):847-52. PubMed ID: 5150357 [No Abstract] [Full Text] [Related] [Next] [New Search]